Megan Martin

Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis

David J. Serisier, Megan Martin, Michael A. McGuckin et al. · JAMA · 2013 · 399 citations

The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial

Geraint B. Rogers, Kenneth D. Bruce, Megan Martin et al. · The Lancet Respiratory Medicine · 2014 · 226 citations

Respiratory Microbiota Composition, Non-cystic Fibrosis Bronchiectasis, Placebo-controlled Bless Trial +8

Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition

Geraint B. Rogers, Chris Gast, Leah Cuthbertson et al. · Thorax · 2013 · 209 citations · Full text

Airway Mucus Hyperconcentration in Non–Cystic Fibrosis Bronchiectasis

Kathryn Ramsey, Alice C.–H. Chen, Giorgia Radicioni et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 125 citations · Full text

Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma

Rhiannon B. Werder, Md Ashik Ullah, Muhammed Mahfuzur Rahman et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 61 citations · Full text